div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 10button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page10jpg target=_blank amp-img class=ts-thumb alt=Page 10: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails10jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 11button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page11jpg target=_blank amp-img class=ts-thumb alt=Page 11: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails11jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 12button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page12jpg target=_blank amp-img class=ts-thumb alt=Page 12: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails12jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 13button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page13jpg target=_blank amp-img class=ts-thumb alt=Page 13: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails13jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 14button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page14jpg target=_blank amp-img class=ts-thumb alt=Page 14: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails14jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 15button div class=ts-image a href=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5page15jpg target=_blank amp-img class=ts-thumb alt=Page 15: medicamentelor C2-01punctul P651: Tratamentul medicamentos al bolnavilor cu boli neurologice inflamator-imune pozitia 5 se abrogä 32 In Anexa nr 4 la secCiunea P6 Programul src=https:reader042vdocumentecomreader042viewer20220405035e2c6045766246269b353887html5thumbnails15jpg width=142 height=106 layout=responsive amp-imga divdiv